NCL News Archive
Sunday, May 21, 2017
FIP Pharmaceutical Sciences World Congress; May 21-24, 2017
NCL’s Director, Scott McNeil will be speaking at the 2017 FIP Pharmaceutical Sciences World Congress (PSWC) in Stockholm, Sweden. Additional details will be posted as soon as available.
For more information and to register for the meeting, please visit: http://pswc2017.fip.org/
Thursday, April 6, 2017
International Advanced Drug Delivery Symposium; April 6-7, 2017
The 2017 International Advanced Drug Delivery Symposium (IADDS) will be held in Taipei, Taiwan, April 6-7, 2017. NCL’s Sr. Principal Scientist in Immunology will be speaking. Further details will be posted soon.
Saturday, April 1, 2017
American Association for Cancer Research (AACR) Annual Meeting, April 1-5, 2017
This year’s AACR annual meeting will take place April 1-5, 2017, at the Walter E. Washington Convention Center in Washington, DC. NCL Sr. Scientist Dr. Jennifer Grossman will be speaking at an NCI-sponsored session on “Resources at the Frederick National Lab for Cancer Research”. If you have questions about how the NCL testing program works, what resources are available, or whether or not your technology would be a good fit for NCL, Jennifer will be available to answer questions.
For more information on this year’s AACR meeting, or to register, please visit:
Monday, March 20, 2017
USP Workshop: Nanomedicines – Technical and Regulatory Perspectives; March 20-22, 2017
The United States Pharmacopeia (USP), along with co-sponsors AAPS and FIP, is hosting a three-day workshop on the technical and regulatory perspectives of nanomedicines. The meeting will be held March 20-22, 2017 in Rockville, MD. The draft agenda has been posted and includes global speakers from industry, academia, various government organizations. NCL’s Director Scott McNeil is slated to speak on day two of meeting and will discuss analytical challenges and advances in nanomedicine characterization.
For more information, please visit: http://www.usp.org/meetings-courses/workshops/nanomedicines-technical-and-regulatory-perspectives
Sunday, March 12, 2017
Society of Toxicology Annual Meeting; March 12-16, 2017
The 2017 SOT Annual Meeting and Tox Expo will be held in Baltimore, MD. Several staff members from the NCL will be attending, including Dr. Stephan Stern, NCL’s Pharmacology & Toxicology Sr. Principal Scientist. Details about NCL talk and poster times will be posted as soon as they’re available.
For more information and to register for the meeting, please visit: http://www.toxicology.org/events/am/AM2017/
Sunday, November 13, 2016
AAPS Annual Meeting; Nov. 13-17, 2016
Dr. Stephan Stern, NCL’s Pharmacology & Toxicology Lead, will be speaking on “NBCD Pharmacokinetics and Bioanalytical Methods to Measure Drug Release”. The talk will be featured in the “Analytical Characterization of Complex Drug Products: Can We Keep Up with Complexity?” session, Wednesday November 16, 9:40 am - 12:00 pm.
For more information and to register for the meeting, please visit: http://www.aaps.org/AMRegister/
Wednesday, November 9, 2016
Equivalence of Complex Drug Products: Scientific and Regulatory Challenges; Nov. 9, 2016
The Non Biological Complex Drugs Working Group, the Nanotechnology Characterization Laboratory (NCL), and the New York Academy of Sciences are co-hosting a conference on the scientific and regulatory challenges associated with evaluating the equivalence of complex drug products. This conference will bring in experts from around the world to discuss approaches for complex drug development and regulation, challenges in the assessment of complex drug equivalence, and differences and commonalities in the behavior of biological and non-biological complex drug families. Speakers include representatives from academia, industry, and regulatory agencies. Abstracts are being accepted for posters, and two abstracts will be selected for inclusion in the oral presentation program.
For more information and to register for the meeting, please visit: http://www.nyas.org/ComplexDrugs16
Monday, October 31, 2016
NCL Lessons Learned Workshop; Oct. 31, 2016
The NCL will be hosting its 8th Lessons Learned Workshop (LLW), October 31, 2016, in Bethesda, Maryland. The LLW is an intensive workshop on the science of preclinical characterization of nanomaterials. This meeting will cover some of the "lessons learned" from the NCL's testing of more than 350 nanotechnology-based candidate cancer treatments and diagnostics.
The half-day session will cover methods for nanomaterial characterization, including strategies for evaluating batch-to-batch consistency, surface characterization, nanomaterial ADME/Tox and PK, sterility and endotoxin contamination, immunotoxicity, and linking physicochemical characterization to safety and efficacy. This session will highlight methods and case studies from the NCL's three-phase Assay Cascade.
For more information and to register for the meeting, please visit: https://ncifrederick.cancer.gov/events/NCL2016/default.asp
Wednesday, October 19, 2016
Applied Pharmaceutical Nanotechnology Meeting; Oct. 19, 2016
NCL’s Dr. Jennifer Grossman will be speaking on the latest capabilities of NCL and collaboration opportunities. She will be available to discuss your specific strategy and ways we might collaborate.
For more information and to register for the meeting, please visit: http://www.bostonsociety.org/APN/
Wednesday, March 15, 2017
NCL Overview Video
Not sure what the NCL does or how we might work together? Watch the NCL’s new overview video describing our services below. You will learn about NCL’s free characterization service for cancer nanomedicines and the types of fee-based services we provide. If you have any questions, please feel free to contact us. A staff member will be happy to answer any questions and help guide you through the application process.
Video produced by AP Media.